Toll-like receptors: the key to the stable door?
暂无分享,去创建一个
[1] D. Schwartz,et al. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans , 2000, Nature Genetics.
[2] P. Detmers,et al. Toll Receptors: a Central Element in Innate Immune Responses , 2002, Infection and Immunity.
[3] S. Akira,et al. A Toll-like receptor recognizes bacterial DNA , 2000, Nature.
[4] T. Calandra,et al. MIF regulates innate immune responses through modulation of Toll-like receptor 4 , 2001, Nature.
[5] Douglas T. Golenbock,et al. Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus , 2000, Nature Immunology.
[6] S. Foster,et al. A cell wall component from pathogenic and non-pathogenic gram-positive bacteria (peptidoglycan) synergises with endotoxin to cause the release of tumour necrosis factor-alpha, nitric oxide production, shock, and multiple organ injury/dysfunction in the rat. , 2001, Shock.
[7] T. Michel,et al. Drosophila Toll is activated by Gram-positive bacteria through a circulating peptidoglycan recognition protein , 2001, Nature.
[8] G. Clermont,et al. Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care , 2001, Critical care medicine.
[9] S. Akira,et al. Cutting Edge: Endotoxin Tolerance in Mouse Peritoneal Macrophages Correlates with Down-Regulation of Surface Toll-Like Receptor 4 Expression1 , 2000, The Journal of Immunology.
[10] Reduced Release of DNA from Streptococcus pneumoniae After Treatment with Rifampin in Comparison to Spontaneous Growth and Ceftriaxone Treatment , 2001, European Journal of Clinical Microbiology and Infectious Diseases.
[11] E. Faist,et al. Removal of Mediators by Continuous Hemofiltration in Septic Patients , 2001, World Journal of Surgery.
[12] A. Aderem,et al. The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[13] Jonathan D. G. Jones,et al. Novel Disease Resistance Specificities Result from Sequence Exchange between Tandemly Repeated Genes at the Cf-4/9 Locus of Tomato , 1997, Cell.
[14] R. Nau,et al. Modulation of Release of Proinflammatory Bacterial Compounds by Antibacterials: Potential Impact on Course of Inflammation and Outcome in Sepsis and Meningitis , 2002, Clinical Microbiology Reviews.
[15] D. Podolsky,et al. Lipopolysaccharide Activates Distinct Signaling Pathways in Intestinal Epithelial Cell Lines Expressing Toll-Like Receptors1 , 2000, The Journal of Immunology.
[16] C. Janeway,et al. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity , 1997, Nature.
[17] S. Opal,et al. High-Dose Antithrombin III in Severe Sepsis: A Randomized Controlled Trial , 2001 .
[18] S. Opal,et al. Bench-to-bedside review: Toll-like receptors and their role in septic shock , 2002, Critical care.
[19] J. Cohen,et al. Adjunctive therapy in sepsis: a critical analysis of the clinical trial programme. , 1999, British medical bulletin.
[20] Takaaki Ohtake,et al. Innate antimicrobial peptide protects the skin from invasive bacterial infection , 2001, Nature.
[21] E. Beutler,et al. Synergy between TLR2 and TLR4: a safety mechanism. , 2001, Blood cells, molecules & diseases.
[22] M. Colonna,et al. TREM-1 amplifies inflammation and is a crucial mediator of septic shock , 2001, Nature.
[23] A. Aderem,et al. The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens , 1999, Nature.
[24] Y. Vodovotz,et al. Hepatocyte toll-like receptor 2 expression in vivo and in vitro: role of cytokines in induction of rat TLR2 gene expression by lipopolysaccharide. , 2000, Shock.
[25] S. Wright,et al. Adhesion-promoting receptors on human macrophages recognize Escherichia coli by binding to lipopolysaccharide , 1986, The Journal of experimental medicine.
[26] S. Opal,et al. Caring for the critically ill patient. High-dose antithrombin III in severe sepsis: a randomized controlled trial. , 2001, JAMA.
[27] R. Ulevitch,et al. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. , 1990, Science.